PA
MKC icon

PharVision Advisers’s McCormick & Company Non-Voting MKC Stock Holding History

PharVision Advisers’s Portfolio MKC Stock Details MKC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,656
Closed -$202K – 427
2024
Q4 		$202K Buy
+2,656
New +$209K 0.17% 302

Other funds holding MKC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PharVision Advisers's MKC Position: Q1 2025 in Review

PharVision Advisers sold out of McCormick & Company Non-Voting (MKC) in Q1 2025, closing a stake of 2,656 shares — an estimated $202K sold.

PharVision Advisers first reported a position in MKC in Q4 2024 and held it in 1 quarter. The position peaked at $202K in Q4 2024. 1,031 funds tracked by Wall St. Rank hold MKC as of Q1 2025.

  • PharVision Advisers reported no remaining McCormick & Company Non-Voting position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 2,656 McCormick & Company Non-Voting shares in Q1 2025, an estimated $202K.
  • PharVision Advisers first reported a position in McCormick & Company Non-Voting in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's McCormick & Company Non-Voting position peaked at $202K in Q4 2024.
  • 1,031 funds tracked by Wall St. Rank held McCormick & Company Non-Voting as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.